Deciphera Pharmaceuticals, Inc.DCPH

時価総額

$20.6億

PER

	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	197	294	120	136	87	65	84
Marketable Securities	-	-	459	416	199	260	-
Marketable Securities, Current	-	-	-	-	-	-	223
Accounts receivable, net	-	-	-	14	21	22	32
Inventory	-	-	-	6	14	21	21
Prepaid expenses and other current assets	1	7	14	12	19	25	22
Total current assets	198	301	593	584	339	393	381
Long-term marketable securities	-	-	-	9	42	15	47
Restricted Investments, Noncurrent	-	1	2	3	3	3	8
Property and equipment, net	1	13	6	10	9	7	5
Operating lease assets	-	-	21	36	37	37	32
Total assets	199	316	622	642	429	454	474
Accounts payable	4	8	20	12	13	19	26
Accrued Liabilities and Other Liabilities	-	14	39	55	81	65	70
Operating lease liabilities	-	-	2	2	3	3	4
Total current liabilities	14	23	60	70	97	86	100
Operating Lease, Liability, Noncurrent	-	-	16	29	28	26	22
Total liabilities	15	36	76	99	125	112	123
Common Stock, Value, Issued	-	0	1	1	1	1	1
Additional paid-in capital	-	575	1,034	1,298	1,359	1,575	1,778
Accumulated other comprehensive income	-	-	0	0	0	-1	1
Accumulated deficit	-196	-296	-488	-754	-1,100	-1,200	-1,400
Total stockholders' equity	184	280	546	544	305	342	351
Total liabilities and stockholders' equity	199	316	622	642	429	454	474